You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VKTX Award Disclosure
Chen Hubert C · SEC Form 4 · Filed Jun 3, 2026
Award
Calculated transaction value
$0
Chen Hubert C Chief Medical Officer
VKTX
Viking Therapeutics
VKTX
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
VKTX daily price context
Close on/before transaction
$31.27
Jun 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 190,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-256039
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Viking Therapeutics, Inc. VKTX Current | Award | Jun 1, 2026 | $0 |